Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL: https://www.bionews.org.uk/page_154143

Lawsuit against Monash IVF over embryo testing method

18 January 2021
Appeared in BioNews 1079

Hundreds of people across Australia are suing the major IVF clinic, Monash IVF, over the destruction of potentially viable embryos.

Between May 2019 and October 2020, Monash IVF offered a new, non-invasive, embryo genetic screening test that has since been suspended. The world-first method had a high false-positive rate, meaning that viable embryos may have been destroyed. The test was used up to 13,000 times and thousands of people could be affected.

Michel Margalit, lead lawyer on the case, said 'I think that there is a real possibility that many, many people will question whether or not they have lost their ability to have children because of this inaccurate testing.'

Instead of procuring an embryo biopsy, the new non-invasive method involved collecting a sample from the liquid surrounding the embryo. Monash IVF told patients that the results of invasive and non-invasive testing were identical in 95 percent of cases. When genetic abnormalities were identified, patients had the choice of saving, destroying or donating the embryos for medical research. The majority of people who were informed that their embryo was abnormal chose not to keep it for use in treatment.

'What we've found out now is [the non-invasive method] perhaps didn't go through the usual robust testing systems that you'd usually expect, which would include publication of the trial data when testing this type of technology, and peer review,' Margalit said.

Monash IVF are offering free treatment to the affected patients; however, this is not feasible for some. Those affected are seeking compensation for the trauma caused and the lost opportunity to have genetically related children, in a multi-million-dollar class action. 'It's an age and time game for a lot of people in IVF,' Margalit added, 'We will be fighting for the rights of these women who have placed their trust in the hands of a medical provider and unknowingly have had devastating consequences.'

SOURCES & REFERENCES
Class action launched against Monash IVF over embryo testing scheme
SBS News |  23 January 2021
Class action launched against Monash IVF over non-invasive embryo testing
ABC |  23 December 2020
Class action lodged against Monash IVF over allegedly bungled screening
The Sydney Morning Herald |  23 January 2021
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
1 February 2021 - by Dr Patrick Foong 
A law firm has filed a class action against Monash IVF, one of Australia's largest IVF clinics, following allegations that the fertility clinic may have destroyed healthy embryos through a defective non-invasive genetic screening test...
17 August 2020 - by Professor Guido Pennings 
More and more fertility centres are imposing expanded carrier screening (ECS) on their gamete donors. ECS allows for the detection of the carrier status of hundreds of recessive disorders in donors who are not at an increased risk...
19 November 2018 - by Ruth Retassie 
A polygenic test to assess embryos for intelligence has been launched and several US IVF clinics are considering offering it to patients...
13 August 2018 - by Charlott Repschlager 
Pre-implantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.